Study With Dapagliflozin

Clinical trial NCT02971618 · COMPLETED

Trial details

NCT number: NCT02971618
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus Type 2

Start date: 2017-02-21
Primary completion: 2018-08-03
Enrollment: 929

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.